Cargando…
Should Metabolic Diseases Be Systematically Screened in Nonsyndromic Autism Spectrum Disorders?
BACKGROUND: In the investigation of autism spectrum disorders (ASD), a genetic cause is found in approximately 10–20%. Among these cases, the prevalence of the rare inherited metabolic disorders (IMD) is unknown and poorly evaluated. An IMD responsible for ASD is usually identified by the associated...
Autores principales: | Schiff, Manuel, Benoist, Jean-François, Aïssaoui, Sofiane, Boepsflug-Tanguy, Odile, Mouren, Marie-Christine, de Baulny, Hélène Ogier, Delorme, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131397/ https://www.ncbi.nlm.nih.gov/pubmed/21760924 http://dx.doi.org/10.1371/journal.pone.0021932 |
Ejemplares similares
-
Correction: Should Metabolic Diseases Be Systematically Screened in Nonsyndromic Autism Spectrum Disorders?
por: Schiff, Manuel, et al.
Publicado: (2011) -
Transient neonatal renal failure and massive polyuria in MEGDEL syndrome
por: Harbulot, Carole, et al.
Publicado: (2016) -
High homocysteine induces betaine depletion
por: Imbard, Apolline, et al.
Publicado: (2015) -
Determining factors of the cognitive outcome in early treated PKU: A study of 39 pediatric patients
por: Herenger, Yvan, et al.
Publicado: (2019) -
Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial
por: Imbard, Apolline, et al.
Publicado: (2022)